Search Results 681-690 of 18356 for prostate cancer
... prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Clinical Trials · Phase III Study Of DCVAC Added To Standard Chemotherapy For Men With Metastatic Castration Resistant Prostate Cancer · More about research at ...
Clinical Trials · A Study To Evaluate Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer · More about research at Mayo ...
Learn about this type of prostate biopsy that combines MRI scans with ultrasound images to target areas of the prostate that are more likely to have cancer.
... prostatic fluid (collected following digital prostate massage) for detection of prostate cancer. Participation eligibility. Participant eligibility includes ...
Study Of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
The purpose of this study is to examine PSMA and C-11 Choline PET in patients with suspected metastatic prostate cancer who have been imaged with 11C-Choline ...
Castration-resistant prostate cancer patients with rising prostatic specific antigen (PSA) are eligible for this study. 11C-Choline PET/CT will be used to ...
Lung cancer, the leading cause of cancer deaths in the U.S., claims more lives each year than colon, prostate, ovarian and breast cancers combined. Treatment ...
Giving CJNJ-67652000 and prednisone may kill more tumor cells in patients with metastatic prostate cancer than giving these drugs alone. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.